The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Impaired glucose tolerance in first‐episode drug‐naïve patients with schizophrenia
Open accessAbstract
Aims To determine whether there is an association between Type 2 diabetes mellitus and schizophrenia, independent of medication. Methods In this cross‐sectional study we performed an oral glucose tolerance test on 38 non‐obese white Caucasians who fulfilled the criteria for first‐episode drug‐naïve schizophrenia, 38 control subjects (matched for age, gender, smoking status, alcohol intake and ethnicity) and 44 first‐degree relatives of the patients. Results The frequency of impaired glucose tolerance (IGT), defined by World Health Organization criteria, was 10.5% (n = 4) in patients with schizophrenia, 18.2% (n = 8) in unaffected relatives and 0.0% in healthy control subjects (χ 2 = 4.22, d.f. = 2, P < 0.05). Conclusions The high point prevalence of IGT in never‐treated patients and relatives supports either shared environmental or genetic predisposition to IGT. Both patients and their relatives present an ideal cost‐effective opportunity to screen for Type 2 diabetes mellitus, as they are both easily identifiable.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Diagnostic and Statistical Manual of Mental Disorders
(2012) · SpringerReference · doi:10.1007/springerreference_121117 · Cited by 20,570
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
(1976) · Medical Entomology and Zoology · Cited by 8,899
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Scale for the Assessment of Negative Symptoms (SANS)*
(1989) · British Journal of Psychiatry · doi:10.1192/s0007125000291502 · Cited by 2,701
Consensus development conference on antipsychotic drugs and obesity and diabetes
American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, & North American Association for the Study of Obesity (2004) · Diabetes Care · doi:10.2337/diacare.27.2.596 · Cited by 1,554
Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes
Boehm, G., Racoosin, J. A., Laughren, T. P., & Katz, R. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.2088-a · Cited by 1,204
Ohlson, L. O., Larsson, B., Svärdsudd, K., Welin, L., Eriksson, H., Wilhelmsen, L., Björntorp, P., & Tibblin, G. (1985) · Diabetes · doi:10.2337/diab.34.10.1055 · Cited by 1,020
The Rising Prevalence of Diabetes and Impaired Glucose Tolerance
Dunstan, D. W., Zimmet, P. Z., Welborn, T. A., de Courten, M. P., Cameron, A. J., Sicree, R. A., Dwyer, T., Colagiuri, S., Jolley, D., Knuiman, M., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.5.829 · Cited by 907
Impaired Fasting Glucose Tolerance in First-Episode, Drug-Naive Patients With Schizophrenia
Ryan, M. C. M., Collins, P., & Thakore, J. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.284 · Cited by 828
Self-citationPoulsen, P., Ohm Kyvik, K., Vaag, A., & Beck-Nielsen, H. (1999) · Diabetologia · doi:10.1007/s001250051131 · Cited by 618
Diet, smoking and cardiovascular risk in people with schizophrenia: Descriptive study
McCreadie, R. G., & Scottish Schizophrenia Lifestyle Group (2003) · British Journal of Psychiatry · doi:10.1192/03-162 · Cited by 546
Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia
Thakore, J., Mann, J., Vlahos, I., Martin, A., & Reznek, R. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801840 · Cited by 332
Self-citationDietary Intervention in Primary Care: Validity of the DINE Method for Diet Assessment
ROE, L., STRONG, C., WHITESIDE, C., NEIL, A., & MANT, D. (1994) · Family Practice · doi:10.1093/fampra/11.4.375 · Cited by 256
Physical consequences of schizophrenia and its treatment
Ryan, M. C. M., & Thakore, J. H. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01646-6 · Cited by 251
Self-citationPREDICTIONS OF CERVICAL CANCER INCIDENCE AND MORTALITY IN ENGLAND AND WALES
Beral, V., & Booth, M. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92944-2 · Cited by 232
Zhang, Z.-J., Yao, Z.-J., Liu, W., Fang, Q., & Reynolds, G. P. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.1.58 · Cited by 230
FAMILY HISTORY OF TYPE 2 DIABETES IN SCHIZOPHRENIC PATIENTS
Mukherjee, S., Schnur, D., & Reddy, R. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91392-5 · Cited by 224
Ryan, M. C. M., Flanagan, S., Kinsella, U., Keeling, F., & Thakore, J. H. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.08.044 · Cited by 186
Self-citationMohan, V., Shanthirani, C. S., & Deepa, R. (2003) · PubMed · Cited by 185
Screening for type 2 diabetes mellitus: a cost-effectiveness analysis
Hoerger, T. J., Harris, R., Hicks, K. A., Donahue, K., Sorensen, S., & Engelgau, M. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-9-200405040-00008 · Cited by 178
Undiagnosed Glucose Intolerance in the Community: the Isle of Ely Diabetes Project
Williams, D. R. R., Wareham, N. J., Brown, D. C., Byrne, C. D., CLARK, P. M. S., Cox, B. D., Cox, L., Day, N., Hales, C. N., Palmer, C., et al. (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb02058.x · Cited by 163
Arranz, B., Rosel, P., Ramírez, N., Dueñas, R., Fernández, P., Sanchez, J. M., Navarro, M. A., & San, L. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1007 · Cited by 161
Hyperglycemia and Diabetes in Patients With Schizophrenia or Schizoaffective Disorders
Cohen, D., Stolk, R. P., Grobbee, D. E., & Wied, C. C. G. (2006) · Diabetes Care · doi:10.2337/diacare.29.04.06.dc05-1261 · Cited by 138
Diabetes Mellitus and Impaired Glucose Tolerance in Patients with Schizophrenia
Subramaniam, M., Chong, S., & Pek, E. (2003) · The Canadian Journal of Psychiatry · doi:10.1177/070674370304800512 · Cited by 135
Pascot, A., Després, J., Lemieux, I., Bergeron, J., Nadeau, A., Prud’homme, D., Tremblay, A., & Lemieux, S. (2000) · Diabetologia · doi:10.1007/s001250051503 · Cited by 120
Cohn, T. A., Remington, G. J., Zipursky, R. B., Azad, A., Connolly, P., & Wolever, T. M. S. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605100608 · Cited by 111
Lamberti, J. S., Crilly, J. F., Maharaj, K., Olson, D. P., Wiener, K., Dvorin, S., Costea, G. O., Bushey, M. P., & Dietz, M. B. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0517 · Cited by 74
Lipoprotein metabolism in visceral obesity.
Asayama, K., Okada, Y., & Kato, K. (1991) · PubMed · Cited by 56
Tai, E. S., Lim, S. C., Tan, B. Y., Chew, S. K., Heng, D., & Tan, C. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00382.x · Cited by 38
Irish diabetes detection programme in general practice
Smith, S. M., Holohan, J., McAuliffe, A., & Firth, R. G. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00998.x · Cited by 38
Larsson, H. E., Elmståhl, S., Berglund, G., & Åhrén, B. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00503.x · Cited by 18
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s
Cited by
Mitchell, A. J., Vancampfort, D., Sweers, K., van Winkel, R., Yu, W., & De Hert, M. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr148 · Cited by 1,082
Impaired Glucose Homeostasis in First-Episode Schizophrenia: A Systematic Review and Meta-analysis
Pillinger, T., Beck, K., Gobjila, C., Donocik, J. G., Jauhar, S., & Howes, O. D. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.3803 · Cited by 457
The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia
Na, K.-S., Jung, H.-Y., & Kim, Y.-K. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.10.022 · Cited by 427
The dietary pattern of patients with schizophrenia: A systematic review
Dipasquale, S., Pariante, C. M., Dazzan, P., Aguglia, E., McGuire, P., & Mondelli, V. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.10.005 · Cited by 394
(Pre)diabetes, brain aging, and cognition
S. Roriz-Filho, J., Sá-Roriz, T. M., Rosset, I., Camozzato, A. L., Santos, A. C., Chaves, M. L. F., Moriguti, J. C., & Roriz-Cruz, M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.12.003 · Cited by 386
Metadata
- Authors
- Spelman, L. M., Walsh, P. I., Sharifi, N., Collins, P., & Thakore, J. H.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2007-03-22
- Volume
- 24
- Issue
- 5
- Pages
- 481-485
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2116680356
- Cited by
- 318
- References
- 35
- FWCI
- 10.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.